pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
Jul 27, 26
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
biopharma dive
Jul 27, 26
Otsuka’s ADHD approval opens up new drug class with $615M opportunity
biospace
Jul 27, 26
Apnimed aspires for up to $160M IPO as sleep apnea pill launch nears
fiercebiotech
Jul 27, 26
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
Jul 27, 26
After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration
fiercebiotech
Jul 27, 26
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
Jul 27, 26
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
biospace
Jul 27, 26
FDA has recommitted to adcomms—but to what end?
biospace
Jul 27, 26
Recon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks
raps
Jul 27, 26
Researchers find similar drug development to reimbursement timelines for major markets
raps
Jul 27, 26
Asia-Pacific Roundup: TGA adopts 23 international scientific guidelines
raps
Jul 24, 26
Sanofi halts development of troubled immune drug in eczema
biopharma dive
Jul 24, 26
Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped
biospace
Jul 24, 26
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
biospace
Jul 24, 26
CHMP recommends Minoryx’s ALD drug, rejects Zevra’s Meplyffa
endpoints
Jul 24, 26
Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma
biopharma dive
Jul 24, 26
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
biospace
Jul 24, 26
Sanofi nixes Kymab-originated OX40L antibody in atopic dermatitis
endpoints
Jul 24, 26
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
fiercebiotech
Jul 24, 26
Opinion: The U.S. pharmaceutical supply chain problem is not about China
stat
Jul 24, 26
Senate advances MAHA-friendly bill for food warning labels and junk food ad bans
stat
Jul 24, 26
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
fiercebiotech
Jul 24, 26
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
fiercebiotech
Jul 24, 26
This Week at FDA: Diamantas touts onshoring efforts, grants for DHTs, and more
raps
Jul 23, 26
Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump
biospace
Jul 23, 26
Lilly, with new data, to seek FDA approval of obesity drug retatrutide
biopharma dive
Jul 23, 26
FDA panel confronting peptide controversy
stat
Jul 23, 26
Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drug
endpoints
Jul 23, 26
Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 data
biospace
Jul 23, 26
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
biospace
← prev
page 38 of 52
next →